Procter & Gamble (NYSE:PG) Stock Sold Off by Rep. David Taylor

Representative David Taylor (Republican-Ohio) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on October 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on October 12th. The trade occurred in the Representative’s “DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)” account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Fifth Third Bancorp (NASDAQ:FITB) on 10/9/2026.
• Purchased $1,001 – $15,000 in shares of RPM International (NYSE:RPM) on 10/9/2026.
• Purchased $1,001 – $15,000 in shares of AT&T (NYSE:T) on 10/9/2026.
• Sold $1,001 – $15,000 in shares of Marathon Petroleum (NYSE:MPC) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Amgen (NASDAQ:AMGN) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Installed Building Products (NYSE:IBP) on 9/8/2026.
• Purchased $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 9/8/2026.
• Sold $1,001 – $15,000 in shares of Amgen (NASDAQ:AMGN) on 8/26/2026.
• Sold $1,001 – $15,000 in shares of Vertex Pharmaceuticals (NASDAQ:VRTX) on 8/26/2026.

Procter & Gamble Price Performance

Shares of PG opened at $159.25 on Friday. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The stock’s 50 day moving average is $146.88 and its two-hundred day moving average is $146.52. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The firm has a market capitalization of $369.89 billion, a PE ratio of 24.06, a P/E/G ratio of 3.96 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last announced its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. The firm had revenue of $21.20 billion for the quarter, compared to analysts’ expectations of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. Procter & Gamble’s quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.98 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s payout ratio is currently 65.71%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Marc S. Pritchard sold 4,030 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total transaction of $579,473.70. Following the sale, the insider directly owned 187,001 shares in the company, valued at $26,888,873.79. This represents a 2.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Andre Schulten sold 3,914 shares of the company’s stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the transaction, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This trade represents a 5.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 15,135 shares of company stock valued at $2,189,970. 0.23% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Procter & Gamble

Hedge funds have recently bought and sold shares of the business. Onyx Bridge Wealth Group LLC raised its holdings in Procter & Gamble by 0.8% in the 3rd quarter. Onyx Bridge Wealth Group LLC now owns 9,906 shares of the company’s stock valued at $1,439,000 after acquiring an additional 76 shares in the last quarter. James T. Borello RIA bought a new position in shares of Procter & Gamble in the 3rd quarter valued at about $96,000. V Square Quantitative Management LLC grew its position in shares of Procter & Gamble by 5.4% during the 3rd quarter. V Square Quantitative Management LLC now owns 52,286 shares of the company’s stock worth $7,596,000 after buying an additional 2,663 shares during the period. YANKCOM Partnership lifted its stake in shares of Procter & Gamble by 9.4% in the 3rd quarter. YANKCOM Partnership now owns 13,540 shares of the company’s stock valued at $1,967,000 after purchasing an additional 1,163 shares during the period. Finally, Financial & Tax Architects LLC grew its position in shares of Procter & Gamble by 4.1% during the 3rd quarter. Financial & Tax Architects LLC now owns 50,341 shares of the company’s stock worth $7,314,000 after buying an additional 1,969 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on PG. Barclays lifted their price objective on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Royal Bank Of Canada dropped their price target on shares of Procter & Gamble from $167.00 to $166.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 6th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $149.00 price target on shares of Procter & Gamble in a report on Monday, August 24th. HSBC reiterated a “hold” rating and set a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. Finally, JPMorgan Chase & Co. decreased their target price on Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating for the company in a research note on Thursday, July 16th. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $162.20.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Improving U.S. sales outlook: UBS maintained its Buy rating and $172 price target, saying better U.S. sales momentum could help P&G outperform expectations when it reports before the market opens on October 22. Procter & Gamble’s improving US sales trends set up a favorable first-quarter report, UBS says
• Positive Sentiment: Defensive dividend appeal: Recent investor-focused coverage highlighted P&G’s 70-year record of dividend increases. That long history, combined with demand for everyday household products, may support the stock as investors seek stable income and less exposure to technology-sector volatility. Procter & Gamble Has Raised Its Dividend for 70 Years
• Neutral Sentiment: Upcoming earnings are the key catalyst: Analysts expect modest revenue growth for fiscal first-quarter 2027, while the company’s latest reported quarter showed revenue growth of 1.5% year over year and earnings that narrowly exceeded consensus. Investors will focus on organic sales, pricing, volumes and updated full-year guidance. Procter & Gamble Set to Release Earnings
• Negative Sentiment: Profit risks remain: Earnings previews warn that rising costs could pressure margins and cause quarterly earnings to decline, reducing the likelihood of a significant earnings beat. P&G’s valuation—about 24 times earnings based on the supplied data—also leaves less room for disappointment. Procter & Gamble Pre-Q1 Earnings
• Negative Sentiment: Some institutional selling: ETFs were reported as net sellers of PG, a modest near-term technical headwind, though this flow does not necessarily signal a change in the company’s long-term fundamentals. ETFs Are Net Sellers of Procter & Gamble

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio’s 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Taylor (Republican Party) ran for election to the U.S. House to represent Ohio’s 2nd Congressional District. He won in the general election on November 5, 2024.

David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor’s career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.